Engineered macromolecular Toll-like receptor agents and assemblies

• Nakkala J.R.
• et al.

Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases.

Acta Biomater. 2021; 123: 1-30

• Lee D.
• et al.

Harnessing innate immunity using biomaterials for cancer immunotherapy.

Adv. Mater. 2021; 33: 2007576

• Patinote C.
• et al.

Agonist and antagonist ligands of toll-like receptors 7 and 8: ingenious tools for therapeutic purposes.

Eur. J. Med. Chem. 2020; 193112238

• Murgueitio M.S.
• et al.

Balancing inflammation: computational design of small-molecule toll-like receptor modulators.

Trends Pharmacol. Sci. 2017; 38: 155-168

• Romerio A.
• Peri F.

Increasing the chemical variety of small-molecule-based TLR4 modulators: an overview.

Front. Immunol. 2020; 11: 1210

• Anwar M.A.
• et al.

Recent clinical trends in Toll-like receptor targeting therapeutics.

Med. Res. Rev. 2019; 39: 1053-1090

• Alkekhia D.
• et al.

Layer-by-layer biomaterials for drug delivery.

Annu. Rev. Biomed. Eng. 2020; 22: 1-24

• Li H.
• et al.

Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates.

Vaccine. 2021; 39: 7446-7456

• Eslami-Kaliji F.
• et al.

Dendritic cells as targets for biomaterial-based immunomodulation.

ACS Biomater. Sci. Eng. 2020; 6: 2726-2739

• Sartorius R.
• et al.

Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines.

npj Vacc. 2021; 6: 127

• Dawulieti J.
• et al.

Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers.

Sci. Adv. 2020; 6: eaay7148

• Shi C.
• et al.

A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.

Sci. Adv. 2022; 8: eabj2372

• Nishiguchi A.
• Taguchi T.

Oligoethyleneimine-conjugated hyaluronic acid modulates inflammatory responses and enhances therapeutic efficacy for ulcerative colitis.

Adv. Funct. Mater. 2021; 31: 2100548

• Shen H.
• et al.

A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury.

Biomaterials. 2022; 280121279

• Lee J.
• et al.

Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis.

Biomaterials. 2017; 120: 94-102

• Francica J.R.
• et al.

Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates.

PLoS Biol. 2019; 17e3000328

• Aswani A.
• et al.

Scavenging circulating mitochondrial dna as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage.

Front. Immunol. 2018; 9: 891

• Mariappan N.
• et al.

Extracellular nucleic acid scavenging rescues rats from sulfur mustard analog-induced lung injury and mortality.

Arch. Toxicol. 2020; 94: 1321-1334

• Sonawane N.D.
• et al.

Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes.

J. Biol. Chem. 2003; 278: 44826-44831

• Yang S.
• May S.

Release of cationic polymer-DNA complexes from the endosome: a theoretical investigation of the proton sponge hypothesis.

J. Chem. Phys. 2008; 129185105

• Boussif O.
• et al.

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 7297-7301

• Srinivasan S.
• Babensee J.E.

Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid).

J. Biomed. Mater. Res. A. 2021; 109: 2269-2279

• Allen R.P.
• et al.

Latent, immunosuppressive nature of poly(lactic-co-glycolic acid) microparticles.

ACS Biomater. Sci. Eng. 2018; 4: 900-918

• Wu C.
• et al.

CpG-PEG conjugates and their immune modulating effects after systemic administration.

Pharm. Res. 2018; 35: 80

• Kakwere H.
• et al.

Systemic immunotherapy with micellar resiquimod-polymer conjugates triggers a robust antitumor response in a breast cancer model.

Adv. Healthc. Mater. 2021; 10e2100008

• Naqvi I.
• et al.

DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists.

Biomaterials. 2022; 283121393

• Deak P.
• et al.

Determining whether agonist density or agonist number is more important for immune activation via micoparticle based assay.

Front. Immunol. 2020; 11: 642

• Nam H.J.
• et al.

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21.

npj Vacc. 2022; 7: 45

• Wang J.
• et al.

MPLA-adjuvanted liposomes encapsulating S-trimer or RBD or S1, but not S-ECD, elicit robust neutralization against SARS-CoV-2 and variants of concern.

J. Med. Chem. 2022; 65: 3563-3574

• Baldwin S.L.
• et al.

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.

PLoS One. 2021; 16e0247990

• Fernández L.
• et al.

Protective efficacy in a hamster model of a multivalent vaccine for human visceral leishmaniasis (MuLeVaClin) consisting of the KMP11, LEISH-F3+, and LJL143 antigens in virosomes, plus GLA-SE Adjuvant.

Microorganisms. 2021; 9: 2253

• Miller S.M.
• et al.

Novel lipidated imidazoquinoline TLR7/8 adjuvants elicit influenza-specific Th1 immune responses and protect against heterologous H3N2 influenza challenge in mice.

Front. Immunol. 2020; 11: 406

• Tondini E.
• et al.

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control.

npj Vacc. 2022; 7: 64

• Yuba E.
• et al.

The application of pH-sensitive polymer-lipids to antigen delivery for cancer immunotherapy.

Biomaterials. 2013; 34: 5711-5721

• Watanabe S.
• et al.

Potent adjuvant effect elicited for tumor immunotherapy by a liposome conjugated pH-sensitive polymer and dendritic cell-targeting Toll-like-receptor ligand.

Vaccine. 2022; 40: 1448-1457

• Zhang H.
• et al.

Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.

Proc. Natl. Acad. Sci. U. S. A. 2021; 118e2005191118

• Takeda Y.
• et al.

Type I interferon-independent dendritic cell priming and antitumor T cell activation induced by a Mycoplasma fermentans lipopeptide.

Front. Immunol. 2018; 9: 496

• Mangas K.M.
• et al.

Vaccine-specific immune responses against Mycobacterium ulcerans infection in a low-dose murine challenge model.

Infect. Immun. 2020; 88e00753-00719

• Zeng W.
• et al.

Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.

Vaccine. 2020; 38: 597-607

• Hanna C.C.
• et al.

Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.

Proc. Natl. Acad. Sci. U. S. A. 2021; 118e2013730118

• Chesson C.B.
• et al.

Nanoscale peptide self-assemblies boost BCG-primed cellular immunity against Mycobacterium tuberculosis.

Sci. Rep. 2018; 8: 12519

• Lynn G.M.
• et al.

Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Nat. Biotechnol. 2020; 38: 320-332

• Baharom F.
• et al.

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.

Nat. Immunol. 2021; 22: 41-52

• Wang X.-J.
• et al.

Antagonistic effect of the glycopeptide from zein on acute alcohol-induced liver injury in mice.

J. Funct. Foods. 2022; 92105062

• Lee E.Y.
• et al.

Helical antimicrobial peptides assemble into protofibril scaffolds that present ordered dsDNA to TLR9.

Nat. Commun. 2019; 10: 1012

• Haderski G.J.
• et al.

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects.

PLoS ONE. 2020; 15e0227940

• Mett V.
• et al.

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.

Commun. Biol. 2021; 4: 466

• Song Y.
• et al.

An injectable silk sericin hydrogel promotes cardiac functional recovery after ischemic myocardial infarction.

Acta Biomater. 2016; 41: 210-223

• Lee W.
• et al.

Prophylactic efficacy of orally administered Bacillus poly-γ-glutamic acid, a non-LPS TLR4 ligand, against norovirus infection in mice.

Sci. Rep. 2018; 8: 8667

• Lima B.V.
• et al.

Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy.

Mater. Today Adv. 2022; 15100252

• Jelacic T.M.
• et al.

Human innate immune cells respond differentially to poly-γ-glutamic acid polymers from Bacillus anthracis and nonpathogenic Bacillus species.

J. Immunol. 2020; 204: 1263-1273

• Herget S.
• et al.

Statistical analysis of the Bacterial Carbohydrate Structure Data Base (BCSDB): characteristics and diversity of bacterial carbohydrates in comparison with mammalian glycans.

BMC Struct. Biol. 2008; 8: 35

• Babazada H.
• et al.

Binding and structure-kinetic relationship analysis of selective TLR4-targeted immunosuppressive self-assembling heparin nanoparticles.

Int. J. Pharm. 2018; 552: 76-83

• Lin C.-A.
• et al.

Hyaluronic acid-glycine-cholesterol conjugate-based nanoemulsion as a potent vaccine adjuvant for T cell-mediated immunity.

Pharmaceutics. 2021; 13: 1569

• Huang H.
• et al.

Hyaluronic acid oligosaccharide derivatives alleviate lipopolysaccharide-induced inflammation in ATDC5 cells by multiple mechanisms.

Molecules. 2022; 27: 5619

• Khongthong S.
• et al.

Characterization and immunomodulatory activity of sulfated galactan from the red seaweed Gracilaria fisheri.

Int. J. Biol. Macromol. 2021; 189: 705-714

• Bi D.
• et al.

Alginate enhances Toll-like receptor 4-mediated phagocytosis by murine RAW264.7 macrophages.

Int. J. Biol. Macromol. 2017; 105: 1446-1454

• Chen L.
• et al.

Drug-loadable calcium alginate hydrogel system for use in oral bone tissue repair.

Int. J. Mol. Sci. 2017; 18: 989

• Jayawardena T.U.
• et al.

Anti-inflammatory effects of sulfated polysaccharide from Sargassum swartzii in macrophages via blocking TLR/NF-Κb signal transduction.

Mar. Drugs. 2020; 18: 601

• Xue M.
• et al.

Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology.

Nutr. Metab. 2019; 16: 87

• Amin M.L.
• et al.

Immunomodulatory properties of photopolymerizable fucoidan and carrageenans.

Carbohydr. Polym. 2020; 230115691

• Yu Q.
• et al.

Fucoidan-loaded nanofibrous scaffolds promote annulus fibrosus repair by ameliorating the inflammatory and oxidative microenvironments in degenerative intervertebral discs.

Acta Biomater. 2022; 148: 73-89

• Mohyuddin S.G.
• et al.

Effect of chitosan on blood profile, inflammatory cytokines by activating TLR4/NF-κB signaling pathway in intestine of heat stressed mice.

Sci. Rep. 2021; 11: 20608

• Hung C.Y.
• et al.

Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection.

Infect. Immun. 2018; 86e00070-18

• Fuchs K.
• et al.

The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size.

EMBO Rep. 2018; 19e46065

• Feng Y.
• et al.

A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages.

Nat. Commun. 2019; 10: 2272

• Hu S.
• et al.

Toll-like receptor 2-modulating pectin-polymers in alginate-based microcapsules attenuate immune responses and support islet-xenograft survival.

Biomaterials. 2021; 266120460

• Mondelo-Macía P.
• et al.

Circulating free DNA and its emerging role in autoimmune diseases.

J. Pers. Med. 2021; 11: 151

• Lazarus R.
• et al.

Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.

J. Infect. 2022; 85: 306-317

• Richmond P.
• et al.

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.

Lancet. 2021; 397: 682-694

• Karime C.
• et al.

Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma.

Expert Opin. Investig. Drugs. 2022; 31: 1-13

• Li Q.
• et al.

CpG oligodeoxynucleotide developed to activate primate immune responses promotes antitumoral effects in combination with a neoantigen-based mRNA cancer vaccine.

Drug Des. Devel. Ther. 2021; 15: 3953-3963

• Leong W.I.
• et al.

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses.

Oncotarget. 2019; 10: 7220-7237

• Fite B.Z.
• et al.

Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.

Sci. Rep. 2021; 11: 927

• Fernández G.
• et al.

TLR4-binding DNA aptamers show a protective effect against acute stroke in animal models.

Mol. Ther. 2018; 26: 2047-2059

• Nagaoka M.
• et al.

Targeted delivery of immunostimulatory CpG oligodeoxynucleotides to antigen-presenting cells in draining lymph nodes by stearic acid modification and nanostructurization.

Int. J. Mol. Sci. 2022; 23: 1350

• Jin J.-O.
• et al.

Soft matter DNA nanoparticles hybridized with CpG motifs and peptide nucleic acids enable immunological treatment of cancer.

J. Control. Release. 2019; 315: 76-84

• Ito K.
• et al.

Development of hydrophobic interaction-based DNA supramolecules as efficient delivery carriers of CpG DNA to immune cells.

J. Pharm. Sci. 2022; 111: 1133-1141

• Zhang X.
• et al.

Tetrahedral-framework nucleic acids carry small interfering RNA to downregulate Toll-like receptor 2 gene expression for the treatment of sepsis.

ACS Appl. Mater. Interfaces. 2022; 14: 6442-6452

• Comberlato A.
• et al.

Spatially controlled activation of Toll-like receptor 9 with DNA-based nanomaterials.

Nano Lett. 2022; 22: 2506-2513

• Oakes R.S.
• et al.

Exploiting rational assembly to map distinct roles of regulatory cues during autoimmune therapy.

ACS Nano. 2021; 15: 4305-4320

• Froimchuk E.
• et al.

Biophysical properties of self-assembled immune signals impact signal processing and the nature of regulatory immune function.

Nano Lett. 2021; 21: 3762-3771

• Pavlick A.
• et al.

Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in patients with high-risk melanoma.

Cancer Immunol. Res. 2020; 8: 70-80

• Löffler M.W.
• et al.

Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma.

Clin. Cancer Res. 2022; 28: 2555-2566

• Komura F.
• et al.

Development of RNA/DNA hydrogel targeting Toll-like receptor 7/8 for sustained RNA release and potent immune activation.

Molecules. 2020; 25: 728

• Tom J.K.
• et al.

Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development.

Trends Biotechnol. 2019; 37: 373-388

• Vishwakarma A.
• et al.

Engineering immunomodulatory biomaterials to tune the inflammatory response.

Trends Biotechnol. 2016; 34: 470-482

• Lee E.Y.
• et al.

A review of immune amplification via ligand clustering by self-assembled liquid-crystalline DNA complexes.

Adv. Colloid Interf. Sci. 2016; 232: 17-24

• Bachmann M.F.
• Jennings G.T.

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Nat. Rev. Immunol. 2010; 10: 787-796

• Lu Y.
• Swartz J.R.

Functional properties of flagellin as a stimulator of innate immunity.

Sci. Rep. 2016; 6: 18379